On ECHEMI
Home > Drugs > Hainan General Alliance Pharmaceutical Co., Ltd.
Hainan General Alliance Pharmaceutical Co., Ltd.
  • Founded in:

    2001-08-30
  • Country:

    China China
  • Address:

    Yonggui Industrial Zone, Xiuying, Haikou, Hainan
  • Tax NO.:

    91460000730054588X
  • Registered Funds:

    180 million yuan
  • Website:

  • Email:

Related Drugs
Lysine aspirin
Name Description Content CAS NO. Registered Holders
DL-Lysine acetylsalicylate

Extract from the above information

More

Extract from the above information

62952-06-1 13
Sodium Morrhuate Injection
This product is a sterile aqueous solution of various sodium salts of fatty acids in cod liver oil.
Name Description Content CAS NO. Registered Holders
Cod liver oil fatty acid sodium salt

This product is a sclerosing agent. Local injection has a strong stimulating effect, causing vascular endothelial damage, fibrosis and hyperplasia, and thus vascular occlusion.

More

This product is a sclerosing agent. Local injection has a strong stimulating effect, causing vascular endothelial damage, fibrosis and hyperplasia, and thus vascular occlusion.

0
Nimustine Hydrochloride for Injection
Nimustine hydrochloride.
Name Description Content CAS NO. Registered Holders
Nimustine hydrochloride

1. Anti-tumor effect: (1) It shows high anti-tumor activity against mouse leukemia L-1210. (2) It has a wide anti-tumor spectrum against mouse transplanted tumors. It shows excellent effects against lymphocytic leukemia L1210, granulocytic leukemia C-1498, plasmacytoma X-5563 (ascites type), Ehrlich's ascites carcinoma, and dural sarcoma MS-147. (3) This agent has a life-extending effect on mice with lymphocytic leukemia L1210 and methylcholanthrene-induced malignant glioma cells transplanted into the brain. 2. Mechanism of action: The main mechanism of action is to alkylate the DNA in the cell and reduce the molecular weight of the DNA, thereby inhibiting DNA synthesis.

More

1. Anti-tumor effect: (1) It shows high anti-tumor activity against mouse leukemia L-1210. (2) It has a wide anti-tumor spectrum against mouse transplanted tumors. It shows excellent effects against lymphocytic leukemia L1210, granulocytic leukemia C-1498, plasmacytoma X-5563 (ascites type), Ehrlich's ascites carcinoma, and dural sarcoma MS-147. (3) This agent has a life-extending effect on mice with lymphocytic leukemia L1210 and methylcholanthrene-induced malignant glioma cells transplanted into the brain. 2. Mechanism of action: The main mechanism of action is to alkylate the DNA in the cell and reduce the molecular weight of the DNA, thereby inhibiting DNA synthesis.

55661-38-6 10
Famotidine for injection
The main ingredient of this product is famotidine. Its chemical name is 3-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]-N-sulfamoylpropionamidine. Molecular formula: C8H15N7O2S3, molecular weight: 337.45.
Name Description Content CAS NO. Registered Holders
Famotidine

This product is a histamine H2 receptor blocker. It has a significant inhibitory effect on gastric acid secretion, and can also inhibit the secretion of pepsin, and has a certain protective effect on animal experimental ulcers. It takes effect about 1 hour after taking the medicine, and the effect can last for more than 12 hours.

More

This product is a histamine H2 receptor blocker. It has a significant inhibitory effect on gastric acid secretion, and can also inhibit the secretion of pepsin, and has a certain protective effect on animal experimental ulcers. It takes effect about 1 hour after taking the medicine, and the effect can last for more than 12 hours.

76824-35-6 69
Ethylaminethiourea
Name Description Content CAS NO. Registered Holders
2-(2-Aminoethyl)isothiourea dihydrobromide

Unspecified

More

Unspecified

56-10-0 8
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.